TY - JOUR
T1 - Qualitative Analysis of Community Support to Methadone Access in Kenya
AU - Ndimbii, James
AU - Guise, Andy
AU - Igonya, Emmy Kageha
AU - Owiti, Frederick
AU - Strathdee, Steffanie
AU - Rhodes, Tim
N1 - Funding Information:
We are grateful to the support of colleagues in Kenya within various community organizations as well as the Department of Health.
Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021
Y1 - 2021
N2 - Background: Methadone, as part of Medically Assisted Therapy (MAT) for treatment of opioid dependence and supporting HIV prevention and treatment, has been recently introduced in Kenya. Few low income settings have implemented methadone, so there is little evidence to guide ongoing scale-up across the region. We specifically consider the role of community level access barriers and support. Objectives: To inform ongoing MAT implementation we implemented a qualitative study to understand access barriers and enablers at a community level. Methods: We conducted 30 semi-structured interviews with people who use drugs accessing MAT, supplemented by interviews with 2 stakeholders, linked to participant observation in a community drop in center within one urban area in Kenya. We used thematic analysis. Results: We developed five themes to express experiences of factors enabling and disabling MAT access and how community support can address these: 1) time, travel and economic hardship; 2) managing methadone and contingencies of life, 3) peer support among MAT clients as treatment ambassadors, 4) family relations, and 5)outreach project contributions. Crosscutting themes address managing socioeconomic constraints and gender inequities. Conclusions: People who use drugs experience and manage socio-economic constraints and gender inequities in accessing MAT with the support of local communities. We discuss how these access barriers could be addressed through strengthening the participation of networks of people who use drugs in drug treatment and supporting community projects working with people who use drugs. We also explore potential for how socio-economic constraints could be managed within an integrated health and social care response.
AB - Background: Methadone, as part of Medically Assisted Therapy (MAT) for treatment of opioid dependence and supporting HIV prevention and treatment, has been recently introduced in Kenya. Few low income settings have implemented methadone, so there is little evidence to guide ongoing scale-up across the region. We specifically consider the role of community level access barriers and support. Objectives: To inform ongoing MAT implementation we implemented a qualitative study to understand access barriers and enablers at a community level. Methods: We conducted 30 semi-structured interviews with people who use drugs accessing MAT, supplemented by interviews with 2 stakeholders, linked to participant observation in a community drop in center within one urban area in Kenya. We used thematic analysis. Results: We developed five themes to express experiences of factors enabling and disabling MAT access and how community support can address these: 1) time, travel and economic hardship; 2) managing methadone and contingencies of life, 3) peer support among MAT clients as treatment ambassadors, 4) family relations, and 5)outreach project contributions. Crosscutting themes address managing socioeconomic constraints and gender inequities. Conclusions: People who use drugs experience and manage socio-economic constraints and gender inequities in accessing MAT with the support of local communities. We discuss how these access barriers could be addressed through strengthening the participation of networks of people who use drugs in drug treatment and supporting community projects working with people who use drugs. We also explore potential for how socio-economic constraints could be managed within an integrated health and social care response.
UR - http://www.scopus.com/inward/record.url?scp=85106339258&partnerID=8YFLogxK
U2 - 10.1080/10826084.2021.1922450
DO - 10.1080/10826084.2021.1922450
M3 - Article
AN - SCOPUS:85106339258
SN - 1082-6084
VL - 56
SP - 1312
EP - 1319
JO - Substance Use and Misuse
JF - Substance Use and Misuse
IS - 9
ER -